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Objective. )e aim of the current study was to compare physical activity and sleep duration between patients with chronic fatigue
syndrome (CFS), patients with ﬁbromyalgia syndrome (FMS), and controls and to examine the association between physical
activity level and sleep duration with symptom severity within these patient groups. Methods. )is study used data of LifeLines,
a general population cohort in which 1.0% (n � 943, 63.7% female, age 44.9 (SD 11.6) years) reported CFS, 3.0% (n � 2, 714; 91.6%
female; age 48.4 (SD 10.7) years) reported FMS, and 95.7% (n � 87, 532; 57.9% female; age 44.3 (SD 12.4) years) reported neither
CFS nor FMS. Physical activity, sleep duration, and symptom severity were assessed by questionnaires and analysed using
ANCOVA and regression analyses, adjusted for age, sex, body mass index, smoking, and educational level. Results. Patients with
CFS and FMS had signiﬁcantly lower physical activity scores (8834 ± 5967 and 8813 ± 5549MET ∗minutes) than controls (9541 ±
5533; p< 0.001). Patients with CFS had the longest sleep duration (466 ± 86 minutes) compared to patients with FMS and controls
(450 ± 67 and 446 ± 56; p< 0.001). A linear association between physical activity, sleep duration, and symptom severity was only
found in controls, in whom higher physical total activity scores and longer sleep duration were associated with a lower symptom
severity. In contrast, quadratic associations were found in all groups: both relatively low and high physical activity scores and
relatively short and long sleep duration were associated with higher symptom severity in CFS, FMS, and controls. Conclusion. )is
study indicates that patients with CFS or FMS sleep longer and are less physically active than controls on average. Both low and
high levels of physical activity and short and long sleep duration are associated with higher symptom severity, suggesting the
importance of patient-tailored treatment.
1. Introduction
Functional somatic syndromes (FSS), including chronic
fatigue syndrome (CFS) and ﬁbromyalgia syndrome (FMS),
are common, disabling, and costly health conditions without
known underlying organic pathology [1–4]. CFS is an illness
characterised by profound disabling unexplained fatigue [5],
while the primary complaint of patients with FMS is un-
explained musculoskeletal pain [6]. Both core symptoms are
typically accompanied by various additional symptoms. )e
etiology of CFS and FMS is assumed to be multifactorial
including biological, psychological, and social contributing
factors [7].
)e role of physical activity and sleep in the patho-
physiology of CFS and FMS is not well understood. Re-
garding physical eﬀort, various studies have evaluated the
ability of patients with CFS or FMS to perform physical
activity, but the results are conﬂicting [8–10]. )ere are also
diﬀerent approaches in the way individuals with CFS and
FMS cope with physical activity. Recent research suggests
that both avoidance of activity and overactivity are associ-
ated with an increase in symptom severity, including pain
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and fatigue [9, 11, 12]. )is indicates that, in patients with
CFS and FMS, both high and low levels of physical activity
may result in higher symptom severity, comparable to what
is observed in the general population [13]. Regarding re-
covery, sleep diﬃculties have been associated with negative
eﬀects on pain and fatigue [14, 15]. A study found that nights
with an unusually long or short sleep duration resulted in
greater fatigue and that moderate sleep duration was as-
sociated with the least fatigue [15]. As with physical activity,
an association between sleep duration and symptom severity
may thus exist in these patient groups [16].
CFS and FMS are known for substantial clinical and
diagnostic overlap.)e two conditions are comorbid: 35% to
75% of patients with CFS met the criteria for FMS [17]. )is
phenomenon resulted in the lumper-splitter discussion [18].
“Lumpers” believe that all FSS result from the same etiology,
and “splitters” take the approach that every separate FSS has
its own speciﬁc background. It is not known to which extent
patients with CFS and FMS diﬀer with regard to physical
activity and sleep. Studies that compare these associations
between patients of one population-based cohort are, to the
best of our knowledge, lacking.
)e aim of this study was to examine whether patients
with CFS, patients with FMS, and controls have diﬀerent
levels of physical activity and sleep duration. Furthermore,
we will examine the degree to which physical activity or sleep
duration is associated with the severity of physical symp-
toms, in CFS, FMS, or controls. We hypothesize that both
too much and too little physical activity and sleep are related
to symptom severity and expect this association to be
stronger in patients with CFS and FMS than controls.
Furthermore, we hypothesize that CFS is more strongly
related to sleep diﬃculties and FMS is more strongly related
to physical activity. )ese hypotheses were tested within
LifeLines, a large population-based cohort study.
2. Materials and Methods
2.1.%eSample. )is study is conducted within the sampling
frame of the LifeLines cohort study [19–21], a general
population cohort in which 1.0% (n � 943; 63.7% female; age
44.9 (SD 11.6) years) reported CFS, 3.0% (n � 2, 714; 91.6%
female; age 48.4 (SD 10.7) years) reported FMS, and 95.7%
(n � 87, 532; 57.9% female; age 44.3 (SD 12.4) years) re-
ported neither CFS nor FMS. )e LifeLines cohort study is
a multidisciplinary prospective population-based cohort
study with a unique three-generation design. LifeLines aims
to examine the health and health-related behaviours of more
than 167,000 persons living in the North East region of the
Netherlands, with a special focus on multimorbidity and
complex genetics. It uses a broad range of research pro-
cedures to assess biomedical, sociodemographics behav-
ioural, physical, and psychological factors that contribute to
health and/or disease of the general population.
2.1.1. Participants. Participants were recruited in two dif-
ferent ways. First, participants aged 25–50 years were invited
through a number of general practitioners from the three
northern provinces of the Netherlands. Second, persons who
were interested to participate in the study could register
themselves via the LifeLines website. Patients who agreed to
participate were asked to invite their partner, parents,
parents-in-law, and children to as well participate in the
LifeLines cohort study. )erefore, participants of all age
were included in the study. General practitioners evaluated
eligibility for participation, whereby persons with severe
psychiatric or physical illness, and those not being able to
visit the general practitioner and to ﬁll in the LifeLines
questionnaires, and/or persons those who did not un-
derstand the Dutch language were excluded from the study.
However, children and parents were not excluded in the case
of the mentioned exclusion criteria, when a representative
was willing to assist these persons in the performance of the
study. In case of pregnancy, participation was rescheduled
until 6 months after pregnancy or 3 months after
breastfeeding.
)e LifeLines cohort study obtained approval by the
Medical Ethical Committee of the UniversityMedical Center
Groningen. All participants received written information on
the purpose and methods of the LifeLines cohort study.
Written informed consent of participants was obtained after
the procedure of the LifeLines cohort study was fully
explained. Data of the LifeLines cohort study are kept
conﬁdential and are only used for medical research.
2.2. Measures
2.2.1. Chronic Fatigue Syndrome and Fibromyalgia
Syndrome. CFS and FMS were assessed by means of a self-
report questionnaire, including a list of chronic disorders
including CFS and FMS. )e participants were asked to
indicate which of these disorders they had or have had. More
than one answer to this question was allowed. Participants
who reported both CFS and FMS were excluded (n � 264),
since we were interested in diﬀerences between both con-
ditions. Controls were deﬁned by the absence of CFS and
FMS.
2.2.2. Physical Activity and Sleep Duration. Physical activity
was assessed by means of the validated Short Questionnaire
to Assess Health-enhancing physical activity (SQUASH)
[22]. )is self-report questionnaire assesses physical activity
undertaken in an average week in the past months across
a set of domains. )ese domains include commuting ac-
tivities (walking or bicycling to/from work or school),
leisure-time activities (walking, bicycling, gardening, and
odd jobs), sports activities, household activities, and activ-
ities at work and school. It is a reliable and valid ques-
tionnaire [22]. )e SQUASH discusses three questions per
activity: days per week of the activity (frequency), average
time per day (duration in minutes), and intensity of the
activity. )e intensity of the physical activity was scored on
a 3-point scale ranging between (1) “Slow,” (2) “Moderate,”
and (3) “Fast.”
)e answers collected with the SQUASH can be ex-
amined as a continuous measure by weighting each type of
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activity by its energy requirements deﬁned in intensity
scores, also referred to as metabolic equivalent of tasks
(METs). METs are deﬁned as multiples of the resting
metabolic rate, thus the energy expenditure at rest. Selected
METvalues are derived using the Ainsworth’s Compendium
of Physical Activities [23]. Based on age and assigned MET
values, physical activities were subdivided into three in-
tensity categories: light, moderate, and vigorous. For adults
aged 18–54 years, the following cutoﬀ values were used: <4.0
MET (light intensity), 4.0 to 6.5 MET (moderate intensity),
and ≥6.5 MET (vigorous intensity), and for adults aged ≥55
years, these cutoﬀ values were <3.0 MET (light), 3.0 to 5.0
MET (moderate), and ≥5.0 MET (vigorous). )e three MET
categories were combined with self-reported intensity for
each activity, resulting in a combined intensity score ranging
from 1 to 9, with 1 being light MET and light self-reported
intensity and 9 being vigorous MET and vigorous self-
reported intensity. )e classiﬁcation of physical activities
according to the combined intensity score was <3 (light
intensity), 3 to 6 (moderate intensity), and ≥6 (vigorous
intensity). )e physical activity scores of the diﬀerent do-
mains were calculated by multiplying duration (minutes per
week) with theMETvalue, taking into account the combined
intensity score. Subjects with unlikely values were excluded
if separate activity categories exceeded plausible values,
more than two activity categories of the questionnaire were
missing, and/or ≥18 hours/day were spent on all activities
together.
Sleep duration was assessed using the question: “How
many minutes do you sleep on average per day?”
2.2.3. Symptom Severity. Symptom severity was assessed
with the 12-item somatization scale of the Symptom
CheckList-90 (SCL-90 SOM) [24]. )e SOM scale measures
self-reported intensity of somatic symptoms. )is scale
consists of 12 somatic symptoms, including a lump in your
throat, faintness or dizziness, feeling weak in parts of your
body, headaches, heavy feelings in arms or legs, hot or cold
spells, nausea or upset stomach, numbness or tingling in
your body, pains in heart or chest, pains in lower back,
soreness of your muscles, and trouble getting your breath.
Participants were asked to what extent they have been
limited by these somatic symptoms in the past seven days.
)e somatic symptoms were scored on a 5-point scale
ranging from (1) “Not at all” to (5) “Extremely.” An addi-
tional item assessing fatigue was used from the RAND-36
[25]: “How much of the time during the past four weeks did
you feel tired?” )is item was scored on a six-point scale
ranging from (1) “All of the time” to (6) “None of the time.”
)e fatigue score was transformed to a 5-point scale with (1)
“None of the time” to (5) “All of the time,” with a combined
score of (3) “A good bit of the time” and (4) “Some of the time”
into (3) “quite a bit” to obtain consistency with the SOM
scale. Symptom severity was calculated by taking the mean
score of the 13 somatic symptoms. )erefore, the total
symptom severity ranged from (1) all symptoms endorsed as
“Not at all or none of the time” to (5) all symptoms endorsed
as “Extremely or all of the time.”
2.2.4. Covariates. Length in centimetres and weight in ki-
lograms were assessed during a basic medical examination at
a local LifeLines research facility. Subsequently, body mass
index (BMI) was calculated as kg/m2. )e smoking status
was assessed using the following question: “Do you smoke
now, or have you smoked in the past month?” Participants
could ﬁll in “yes” or “no.” Educational level was assessed
using the following question: “What is your highest com-
pleted education?,” resulting in information about low,
middle, and high educational level. Low educational level
was deﬁned as lower secondary education or less, middle
educational level was deﬁned as higher secondary education,
and high educational level was deﬁned as tertiary education.
2.3. Statistical Analyses. For all continuous variables, means± standard deviations (SDs) were calculated. One-way an-
alyses of variance (ANOVA) were performed for continuous
data, to test the diﬀerences in sample characteristics. Dif-
ferences in symptom severity were also investigated between
males and females within the diﬀerent study groups. In
addition, χ2 tests were performed for categorical data. For
continuous variables, analyses of covariance (ANCOVA)
with post hoc Bonferroni correction were performed to
examine diﬀerences in physical activity level and sleep
duration between patients with CFS, patients with FMS, and
controls. In addition, sex diﬀerences in physical activity and
sleep duration were explored. Linear and quadratic re-
gression analyses were conducted using standardized vari-
ables to examine how physical activity and sleep duration
were associated with symptom severity in the diﬀerent
groups. Four regression models were performed: both linear
and regression analyses for physical activity and for sleep
duration. All analyses were adjusted for age, sex, BMI,
smoking status, and educational level, since they are known
to be related to CFS [26, 27], FMS [28–30], physical activity
[31, 32], and sleep [33, 34]. All analyses were performed
using SPSS version 20. Statistical signiﬁcance was deﬁned as
p< 0.05.
3. Results
3.1. Sample Characteristics. Data were available for 91,453
participants; descriptives, including age, BMI, education,
SOM score, sex, and smoking, are shown in Table 1. Of these
participants, 1.0% (n � 943) reported CFS, 3.0% (n � 2, 714)
reported FMS, and 95.7% (n � 87, 532) reported neither CFS
nor FMS. Women were most prevalent in all groups. )e
mean age varied between 44.3 ± 12.4 for controls, 44.9 ± 11.9
for patients with CFS, and 48.4 ± 10.7 years for patients with
FMS. Female CFS patients and controls reported signiﬁ-
cantly higher symptom severity (2.1 ± 0.6 and 1.5 ± 0.4,
respectively) compared to males (1.9 ± 0.6 and 1.4 ± 0.3),
while no diﬀerence in symptom severity was found in female
FMS patients (2.0 ± 0.5) compared to male FMS patients (1.9± 0.5).
3.2. Physical Activity and Sleep Duration. Physical activity
levels in patients with CFS, patients with FMS, and controls
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are shown in Figure 1(a). ANCOVA analysis revealed sig-
nicant groups’ dierences (F(7, 76182)  303, p< 0.001).
Post hoc comparisons with Bonferroni correction indicated
that patients with CFS and FMS had a signicantly lower
physical total activity score than controls (8834 ± 5967 and
8813 ± 5549 MET ∗ minutes, respectively, versus 9541 ±
5533; both p< 0.001). ere was no signicant dierence in
physical total activity score between patients with CFS and
FMS (p  0.99). Lastly, males were signicantly more
physically active than females among all three study groups.
Sleep duration in patients with CFS, patients with FMS, and
controls is shown in Figure 1(b). ANCOVA analysis revealed
signicant groups’ dierences (F(7, 39438)  222, p≤ 0.001).
Post hoc comparisons with Bonferroni correction indicated
that patients with CFS had the longest sleep duration (466 ± 86
minutes) compared to patients with FMS and controls (450 ±
67 and 446 ± 56, respectively, both p< 0.001), while no dif-
ference was found between patients with FMS and controls
(p  0.846). Furthermore, female CFS patients and controls
reported signicantly longer sleep duration (474± 84 and 453±
59 minutes, respectively) than males in the corresponding
groups (453 ± 87 and 437 ± 50 minutes), while no dierence in
sleep duration was found between female FMS patients (451 ±
66 minutes) and male FMS patients (442 ± 80 minutes).
3.3. Physical Activity or Sleep Duration Associated with
Symptom Severity. Physical activity and sleep duration
showed both linear and quadratic associations with symp-
tom severity. Results of both linear and quadratic regression
analyses are shown in Table 2. Linear regression analyses
showed that, only in controls, physical total activity score
(model 1) and sleep duration (model 2) were related to
symptom severity; controls with a higher physical total
activity score or longer sleep duration reported a slightly
lower symptom severity. No signicant linear associations
were found in patients with CFS or FMS between physical
total activity score or sleep duration and symptom severity.
Quadratic regression analyses indicated a signicant
association between total physical activity score in CFS,
FMS, and controls (model 3). Both linear and quadratic
terms were signicant in FMS and controls, and only the
quadratic term, but not the linear, was signicant in CFS.
us, patients with CFS, patients with FMS, and controls
Table 1: Sample characteristics.
Pairwise comparisonsc; p value
CFS FMS Controls CFS vs FMS CFS vs controls FMS vs controls
Mean (SD)
Number (%) 943 (1.0) 2714 (3.0) 87532 (95.7)
Agea 44.9 (11.6) 48.4 (10.7) 44.3 (12.4) <0.001 0.137 <0.001
BMI (kg/m2)a 26.4 (4.8) 27.8 (5.3) 26.0 (4.3) <0.001 0.407 <0.001
Symptom severity (1–5)a 2.0 (0.6) 2.0 (0.5) 1.5 (0.4) 0.038 <0.001 <0.001
n (%)
Educationb
Low 319 (33.8) 1193 (44.0) 25,418 (29.0) <0.001 <0.001 <0.001
Middle 377 (40.0) 1055 (38.9) 34,211 (39.1)
High 213 (22.6) 377 (13.9) 25,697 (29.7)
Femaleb 601 (63.7) 2485 (91.6) 50,705 (57.9) <0.001 <0.001 <0.001
Smokingb 257 (27.3) 609 (22.4) 18,520 (21.2) 0.002 <0.001 0.145
CFS  chronic fatigue syndrome; FMS  bromyalgia syndrome. aANOVA; bχ2 test; cBonferroni correction for continuous and χ2 test for categorical
variables.
p < 0.001





































Figure 1: (a) Physical activity. (b) Sleep duration. CFS  chronic fatigue syndrome; FMS  bromyalgia syndrome. Analyses of covariance
and Bonferroni correction were done, adjusted for age, sex, BMI, smoking, and education.
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with relatively low and high physical activity scores reported
higher symptom severity than those with moderate physical
activity scores. Furthermore, all three groups showed sig-
niﬁcant quadratic associations between sleep duration and
symptom severity (model 4). Both linear and quadratic sleep
terms were signiﬁcant in patients with CFS and controls,
while only the quadratic but not the linear sleep term was
signiﬁcant in patients with FMS. )us, patients with CFS,
patients with FMS, and controls with short or long sleep
duration reported a higher symptom severity than those
with moderate sleep duration.
4. Discussion
)is study revealed that patients with CFS and FMS were
signiﬁcantly less physically active than controls. Further-
more, patients with CFS reported longer sleep duration than
patients with FMS and controls. Only in controls, physical
total activity score and sleep duration were linearly related to
symptom severity, with both higher physical total activity
score and higher sleep duration being associated with
slightly lower symptom severity. Quadratic associations
were present in all groups; both relatively high and low
physical activity levels were associated with higher symptom
severity in patients with CFS, patients with FMS, and
controls; and both relatively long and short sleep duration
were associated with higher symptom severity in patients
with CFS, patients with FMS, and controls.
)e main strength of this study is the large population
cohort. To the best of our knowledge, this is the ﬁrst study
that evaluates physical activity and sleep duration in patients
with CFS and FMS in one large population cohort. A suf-
ﬁcient number of patients with CFS and FMS were iden-
tiﬁed, allowing for meaningful statistical comparisons.
Moreover, the large number of patients enabled examining
the association between sleep duration, physical activity, and
symptom severity in CFS, FMS, and controls. Both patients
and controls with diﬀerent physical activity or sleep duration
outcomes were therefore present in the cohort. Finally, since
LifeLines is a large cohort study with extensive measure-
ments, adjusting for important covariates such as age, sex,
BMI, smoking status, and educational level was possible.
Our study also contained limitations, including the use
of a self-report questionnaire for the assessment of CFS and
FMS. Instead of current diagnoses, our questionnaire asked
for a history of CFS and FMS. A previous study in a general
population cohort from the same geographical area in-
dicated that about 75% and 100% of the participants that
reported a history of CFS and FMS, respectively, still had this
syndrome at the time of reporting [35]. In addition, self-
reports may underestimate the amount of persons with FSS.
)is seems not likely in our study because the prevalence
rates for CFS and FMS were comparable to previous studies
[27, 29]. Moreover, the majority of the patients with CFS and
FMS in the current study recently experienced fatigue and
musculoskeletal pain. Furthermore, subjective measure-
ments were used to assess sleep duration and physical ac-
tivity, instead of objective measures. For example, sleep
duration was assessed using a single question, so participants
may have interpreted this diﬀerently (e.g., time in bed, actual
time sleep, and inclusion of naps). A ﬁnal limitation is that
the cross-sectional design did not allow conclusions on
cause-and-eﬀect relationships.
In line with previous ﬁndings, this study revealed that
both patients with CFS and FMS were signiﬁcantly less
physically active than controls [36, 37]. However, it should
be mentioned that self-reported questionnaires to assess
physical activity levels in these patient groups have shown
a low reliability [38, 39]. In contrast to our hypothesis, no
diﬀerence in physical activity was found between patients
with CFS and FMS. Lower activity levels in patients with CFS
or FMS might be explained by the substantial limitations in
physical functioning that may be caused by their symptoms
[9]. In addition, a lack of physical activity might also con-
tribute to physical deconditioning, further increasing
symptom severity [12, 40]. We found that both low and high
physical activity levels in patients with CFS, patients with
FMS, and controls were associated with the reporting of
more symptoms. )is ﬁnding stresses the close relationship
between physical activity and the experience of symptoms.
)us, on the one hand, low activity levels may be associated
with the experience of more and more severe symptoms,
while on the other hand, high physical activity level may
exacerbate symptoms in CFS and FMS [9, 11, 12].
Diﬀerences between patients with CFS and FMS were
found for sleep duration, since patients with CFS were found
to report longer sleep duration than patients with FMS and
controls. However, misestimation of sleep duration appears
Table 2: Associations between physical activity, sleep duration, and symptom severity.
CFS FMS Controls
B 95% CI B 95% CI B 95% CI
Linear
(1) Physical total activity score −0.007 −0.047, 0.032 −0.009 −0.031, 0.012 −0.007∗∗ −0.009, −0.004
(2) Sleep duration −0.005 −0.045, 0.036 −0.009 −0.036, 0.017 −0.004∗ −0.008, −0.001
Quadratic
(3) Physical total activity score (linear term) −0.042 −0.091, 0.008 −0.046∗∗ −0.073, −0.020 −0.009∗∗ −0.012, −0.006
Physical total activity score (quadratic term) 0.020∗ 0.003, 0.038 0.019∗∗ 0.011, 0.027 0.001∗∗ 0.001, 0.002
(4) Sleep duration (linear term) −0.045∗ −0.089, 0.00 −0.021 −0.047, 0.005 −0.007∗∗ −0.011, −0.003
Sleep duration (quadratic term) 0.017∗∗ 0.008, 0.025 0.040∗∗ 0.031, 0.049 0.00∗∗ 0.00, 0.00
CFS � chronic fatigue syndrome; FMS � ﬁbromyalgia syndrome. ∗p≤ 0.05; ∗∗p≤ 0.001. Multivariable regression analyses were done, adjusted for age, sex,
BMI, smoking, and education.
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common in patients with CFS and FMS, particularly in
patients having a poor sleep quality [41, 42]. Nevertheless,
our results are in accordance with our hypothesis and might
be due to the primary complaint of disabling fatigue in
patients with CFS [5, 43, 44]. Furthermore, our results are in
line with a recent study that reported that nights with an
unusually long or short sleep duration resulted in greater
fatigue, and that moderate sleep duration was associated
with the least fatigue [15].
Our study also revealed diﬀerences between patients, as
illustrated by the ﬁnding of quadratic associations of
symptom severity with physical activity and sleep. )ese
quadratic associations indicate that the pathophysiological
role of physical activity and sleep varies not only between but
also within patient groups with CFS or FMS. Treatment
aimed at reducing symptoms might therefore better be
tailored to individual patients. )is is mainly important
since both CFS and FMS are characterised both by non-
restorative sleep and intolerance to physical exercise. Since
the LifeLines cohort is a large population cohort study that
aims to study a wide spectrum of mental and somatic dis-
orders, it was not feasible to more extensively assess lifestyle
factors such as physical activity and sleep in CFS and FMS
during the baseline assessment because of practical limita-
tions. We aim to include objectively measured lifestyle
factors in CFS and FMS in future assessment waves. Further
studies will be necessary to determine the eﬀect of objectively
measured physical activity or sleep duration, by using, for
instance, polysomnography or accelerometers. Furthermore,
the association between sleep duration and symptom se-
verity was found to vary between diﬀerent patients.
)erefore, studies that evaluate how sleep duration and
physical activity are related to symptom severity within
individual patients, so called idiographic research [45], is
recommended to further study the role of sleep and physical
activity in patients with CFS and FMS.
5. Conclusion
)is study revealed that, on average, patients with CFS and
FMS sleep longer and are less physically active than controls
and that both high and low levels of physical activity and
sleep duration are associated with higher symptom severity.
Diﬀerences were found within patient groups, suggesting
etiological heterogeneity in these patients and thus the
importance of patient-tailored treatment.
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